We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$4B
AUM Growth
-$1.25B
Cap. Flow
-$1.28B
Cap. Flow %
-32.02%
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487

Sector Composition

Rank Sector Weight
1 Healthcare 1.79%
2 Communication Services 1.57%
3 Technology 1.13%
4 Consumer Discretionary 1.05%
5 Financials 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUR icon
1076
CALL
Pluri
PLUR
$17M
$68K ﹤0.01%
1,775
NKE icon
1077
CALL
Nike
NKE
$64.1B
$66K ﹤0.01%
+500
New +$69.5K
TRIT
1078
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
$65K ﹤0.01%
+9,000
New +$73.3K
LSAK icon
1079
CALL
Lesaka Technologies
LSAK
$384M
$62K ﹤0.01%
+11,000
New +$57.5K
UUUU icon
1080
PUT
Energy Fuels
UUUU
$2.68B
$62K ﹤0.01%
11,000
RUN icon
1081
PUT
Sunrun
RUN
$2.26B
$60K ﹤0.01%
1,000
SCYX icon
1082
CALL
SCYNEXIS
SCYX
$37.4M
$60K ﹤0.01%
+938
New +$61.5K
GNPK.U
1083
DELISTED
Genesis Park Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of
GNPK.U
$60K ﹤0.01%
5,200
-9,800
-65% -$110K
AMRN
1084
Amarin Corp
AMRN
$297M
$59K ﹤0.01%
475
-775
-62% -$104K
AMRN
1085
PUT
Amarin Corp
AMRN
$297M
$59K ﹤0.01%
475
-1,625
-77% -$219K
SIOX
1086
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$59K ﹤0.01%
22,500
-34,000
-60% -$96.2K
SIOX
1087
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$59K ﹤0.01%
22,500
ATOS icon
1088
CALL
Atossa Therapeutics
ATOS
$23M
$53K ﹤0.01%
+1,667
New +$60.9K
OXY icon
1089
PUT
Occidental Petroleum
OXY
$55.7B
$53K ﹤0.01%
2,000
-8,000
-80% -$200K
SWCH
1090
CALL
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$52K ﹤0.01%
+3,200
New +$53.3K
RNLX
1091
DELISTED
Renalytix plc American Depositary Shares
RNLX
$51K ﹤0.01%
+2,000
New +$50.1K
AWH
1092
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$51K ﹤0.01%
+500
New +$55K
SWN
1093
PUT
DELISTED
Southwestern Energy Company
SWN
$47K ﹤0.01%
10,000
ADT icon
1094
ADT
ADT
$5.43B
$46K ﹤0.01%
5,500
CNET icon
1095
CALL
ZW Data Action Technologies
CNET
$5.65M
$46K ﹤0.01%
+865
New +$50K
GGAL icon
1096
Galicia Financial Group
GGAL
$7.89B
$46K ﹤0.01%
+6,000
New +$47.4K
OTIC
1097
PUT
DELISTED
Otonomy, Inc.
OTIC
$46K ﹤0.01%
+18,000
New +$73.8K
ACGN
1098
DELISTED
Aceragen Inc
ACGN
$45K ﹤0.01%
+2,043
New +$153K
IMVT icon
1099
Immunovant
IMVT
$7.93B
$40K ﹤0.01%
+2,500
New +$65.9K
COWN
1100
CALL
DELISTED
Cowen Inc. Class A Common Stock
COWN
$39K ﹤0.01%
+1,100
New +$35.4K

Similar funds

SG3 Management's Q1 2021 Portfolio in Review

As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.

Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.

  • SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
  • SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
  • SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
  • SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
  • SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
  • SG3 Management opened 626 new positions and closed 487 in Q1 2021.
  • SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.

Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.